US Patent Litigations are now available. Check here

IP Verse

Arena Pharmaceuticals patent opposition analysis

Get Patent Opposition Report for Arena Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Arena Pharmaceuticals opposed by its competitors

Explore Arena Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3582814	May 1, 2024	Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal Manifestations	2
EP3860590	Jun 7, 2023	Methods For The Treatment Of Scleroderma	2
EP3310760	Oct 19, 2022	Crystalline L-Arginine Salt Of (R)-2-(7-(4-Cyclopentyl-3-(Trifluoromethyl)Benzyloxy)-1,2,3,4-Tetrahydrocyclo-Penta[B]Indol-3-Yl)Acetic Acid(Compound1) For Use In Sipi Receptor-Associated Disorders	2

Top competitors of Arena Pharmaceuticals

HAMM&WITTKOPP PATENTANWALTE PARTMBB

MAIWALD

SANDOZ